Yumi Yamamoto

Prediction of human CNS pharmacokinetics using a physiologically-based pharmacokinetic modeling approach

Yumi Yamamoto, Pyry A. J. Välitalo, Yin Cheong Wong et al. · European Journal of Pharmaceutical Sciences · 2017 · 80 citations · Full text

Human Cns Pharmacokinetics, Pharmacokinetic Modeling, Neurophysiology +11

Ocrelizumab in relapsing and primary progressive multiple sclerosis: Pharmacokinetic and pharmacodynamic analyses of OPERA I, OPERA II and ORATORIO

Ekaterina Gibiansky, Claire Petry, François Mercier et al. · British Journal of Clinical Pharmacology · 2020 · 77 citations · Full text

Disease Progression, Neurological Disorder, Immunodeficiencies +21

Predicting Drug Concentration‐Time Profiles in Multiple CNS Compartments Using a Comprehensive Physiologically‐Based Pharmacokinetic Model

Yumi Yamamoto, Pyry A. J. Välitalo, Dymphy Huntjens et al. · CPT Pharmacometrics & Systems Pharmacology · 2017 · 75 citations · Full text

Multiple Cns Compartments, Cns Compartments, Drug Concentration‐time Profiles +19

A Generic Multi-Compartmental CNS Distribution Model Structure for 9 Drugs Allows Prediction of Human Brain Target Site Concentrations

Yumi Yamamoto, Pyry A. J. Välitalo, Dirk‐Jan van den Berg et al. · Pharmaceutical Research · 2016 · 68 citations · Full text

Mycobacteria in the intestine of Japanese patients with inflammatory bowel disease.

Kensuke Suenaga, Yuya Yokoyama, Katsuichiro Okazaki et al. · PubMed · 1995 · 60 citations